ANIK Stock Analysis: Buy, Sell, or Hold?
ANIK - Anika Therapeutics Inc
$14.61
-0.11 (-0.75%)
▼
5d:
+0.07%
30d:
-4.76%
90d:
+1.74%
BUY
HIGH Confidence
Analysis Updated: Jun 15, 2026 12:00 AM ET
Earnings: Jul 29, 2026
Get Alerted When ANIK Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
✅ BUY SIGNAL: ANIK trading at deep discount. Market pricing in -4.3% annual earnings decline, creating value opportunity for patient investors.
✅ BUY SIGNAL: ANIK trading at deep discount. Market pricing in -4.3% annual earnings decline, creating value opportunity for patient investors.
Long-Term Wealth Forecast (2031)
Based on Analyst Consensus Growth & Historical Valuation
0% (Stagnation)
50% (Hyper Growth)
EST. PRICE IN 2031
$16.95
Based on 8.1% avg growth
INTRINSIC VALUE TODAY
$10.52
Trading above historical range
How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 25.0x Exit PE.
In-depth Analysis How we analyze
Valuation Analysis: ANIK is currently trading at $14.61, which is considered slightly low relative to its 30-day fair value range of $14.54 to $14.98. From a valuation perspective, the stock is trading at a discount (Forward PE: 31.8) compared to its historical average (36.3). Remarkably, the market is currently pricing in an annual earnings decline of 4.3% over the next few years. This aligns with recent fundamental challenges.
Technical Outlook: Technically, ANIK is in a strong uptrend. The price is currently testing key support at $14.20. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ANIK has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.50 (+19.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Technical Outlook: Technically, ANIK is in a strong uptrend. The price is currently testing key support at $14.20. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: ANIK has a strong technical setup (60/100), with favorable trendlines, momentum, and price action for short-term traders. Wall Street analysts see significant upside, with an average price target of $17.50 (+19.8%). Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.
Quick Decision Summary
Current Position
SLIGHTLY LOW
Historical Trading Range
$14.54 -
$14.98
Company Quality Score
58/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
88.1%
All Signals
- BULLISH: Price oversold vs 30-day range
- BULLISH: Strong technical setup (60/100)
- BULLISH: High volume confirmation
- BULLISH: Trading below Wall St target ($17.50)
Trading Range Analysis
30-Day Trading Range
$14.54 -
$14.98
Current vs Trading Range
SLIGHTLY LOW
Support & Resistance Levels
Support Level
$14.20
Resistance Level
$15.14
Current Trend
Strong Uptrend
Technical data as of
Jun 15, 2026
Fundamental Context
Forward P/E (Next Year Est.)
31.76
Wall Street Target
$17.50
(+19.8%)
Revenue Growth (YoY)
13.2%
Earnings Growth (YoY)
-50.5%
Profit Margin
-9.5%
Valuation Discount vs History
-4.3% cheaper
PE vs Historical
31.8 vs 36.3
CHEAP
Market-Implied Price Targets
If current PE multiple persists
Implied Growth (YoY):
-4.3%
(market-implied from PE analysis)
1-Year Target
$13.98
(-4%)
2-Year Target
$13.38
(-8%)
3-Year Target
$12.81
(-12%)
3-Yr Target (if PE normalizes)
(PE: 32→36)
$14.64
(+0%)
3-Year Scenarios
Using analyst projected EPS growth
Bull:
(PE: 31.8, Growth: 12.2%)
$20.63
(+41%)
Base:
(SPY PE: 21.8, Growth: 12.2%)
$14.15
(-3%)
Bear:
(PE: 18.5, Growth: 12.2%)
$12.03
(-18%)
💡
Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 31.8 to 36.3
Stabilization Target:
$16.70
(+14.3%)
PE Expansion Potential:
+14.3%
Share & Embed Analysis
Last updated: June 16, 2026 7:28 AM ET
Data refreshes hourly during market hours. Next update: 8:28 AM
Data refreshes hourly during market hours. Next update: 8:28 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is ANIK showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Drug Manufacturers - Specialty & Generic Stocks
Top-rated stocks in Drug Manufacturers - Specialty & Generic by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
NBIX
Neurocrine Biosciences I… |
STRONG BUY
25 analysts |
$193 | 61 BUY |
|
ZTS
Zoetis Inc |
BUY
20 analysts |
$125 | 61 BUY |
|
LNTH
Lantheus Holdings Inc |
STRONG BUY
13 analysts |
$105 | 61 BUY |
|
BCRX
BioCryst Pharmaceuticals… |
STRONG BUY
12 analysts |
$21 | 62 BUY |
|
UTHR
United Therapeutics Corp… |
STRONG BUY
15 analysts |
$665 | 58 HOLD |
Advanced ANIK Option Strategies
Professional options setups generated by AI based on today's ANIK price and gamma walls.
